The Weekly Roundup

February 05, 2016 | Pamela Youngberg Dickson

The opioid abuse epidemic continues to garner attention on Capitol Hill. According to the CDC, more Americans die of overdoses than in vehicular accidents. Bipartisan support has been growing for bills that will curb the epidemic of opioid addiction, and individual states have been working to enact legislation enabling pharmacists to prescribe life-saving naloxone. We’re watching developments weekly and we’ll try to keep you up-to-date, but if you have the time today or this weekend, here’s an interesting position paper from the New England Journal of Medicine.

Here are a few more pieces we think you'll like:

Continue reading →

Medicare Part D and the Independent Pharmacy

April 27, 2015 | Tim Gallagher

CMS, the Centers for Medicare and Medicaid Services, recently finalized its policy updates for Medicare health and Part D drug plans.

CMS states: “As the Medicare Advantage marketplace continues to grow, consumers are getting access to better care through more choice and competition. Seniors and people with disabilities, including the dual-eligible population, will continue to have an extensive choice of plans, affordable premiums, and better and more transparent information about provider networks and pharmacies.”

After the Aetna fiasco this year, CMS is taking a closer look at preferred networks and access to pharmacies. This should be good for independents. The final changes should drive important improvements to the accuracy and transparency of provider networks, and continue to promote improvements in quality of care for beneficiaries.

What does this mean for pharmacy?

Continue reading →